Clorox (NYSE: CLX) director adds deferred stock units via 2025 awards

Rhea-AI Filing Summary

Clorox Co. director deferred stock unit grants and reinvestments

A director of Clorox Co. reported multiple acquisitions of deferred stock units tied to Clorox common stock during 2025. On several dates, including 02/14/2025, 05/09/2025, 08/29/2025, and 11/06/2025, small fractional amounts of deferred stock units were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan, each at an exercise price of $0.0000 and on a 1-for-1 basis into Clorox stock.

On 12/31/2025, the director received an additional 1,637.8577 deferred stock units as an annual award under the 2005 Stock Incentive Plan, also with a conversion price of $0.0000. Following these transactions, the director beneficially owned a total of 4,471.9997 deferred stock units, which will be settled 100% in Clorox stock upon retirement or other termination of service as a director.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Charter Julia

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/14/2025		A(2)	V	22.4752		(3)	(3)	Common Stock	22.4752	$0.0000	2,747.499	D
Deferred Stock Units	(1)	05/09/2025		A(2)	V	24.8735		(3)	(3)	Common Stock	24.8735	$0.0000	2,772.3725	D
Deferred Stock Units	(1)	08/29/2025		A(2)	V	29.0841		(3)	(3)	Common Stock	29.0841	$0.0000	2,801.4566	D
Deferred Stock Units	(1)	11/06/2025		A(2)	V	32.6854		(3)	(3)	Common Stock	32.6854	$0.0000	2,834.142	D
Deferred Stock Units	(1)	12/31/2025		A(4)		1,637.8577		(3)	(3)	Common Stock	1,637.8577	$0.0000	4,471.9997	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.

	By Jinho Joo, Attorney-in-Fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CLX report in this Form 4?

A Clorox Co. director reported acquiring multiple deferred stock units linked to Clorox common stock during 2025, including small dividend reinvestments and an annual equity award.

How many deferred stock units does the CLX director own after these transactions?

After the reported 2025 transactions, the director beneficially owned 4,471.9997 deferred stock units tied to Clorox common stock.

On what dates in 2025 were Clorox (CLX) dividend reinvestment deferred stock units acquired?

Deferred stock units were acquired through dividend reinvestment on 02/14/2025, 05/09/2025, 08/29/2025, and 11/06/2025 under the Independent Directors' Deferred Compensation Plan.

What was the large Clorox (CLX) deferred stock unit award on 12/31/2025?

On 12/31/2025, the director received an annual award of 1,637.8577 deferred stock units under the 2005 Stock Incentive Plan, with an exercise price of $0.0000.

How will the Clorox (CLX) deferred stock units be settled for the director?

The filing states that the deferred stock units will be settled 100% in Clorox stock when the director retires or otherwise terminates service as a director.

Are the Clorox (CLX) deferred stock unit transactions cash-based?

No, each reported deferred stock unit in the table carries a conversion or exercise price of $0.0000, reflecting equity-based compensation rather than cash purchases.